Levofloxacin Injection, Solution
Product Images NDC 68083-415

This is a description of Levofloxacin in 5% Dextrose Injection. It is a solution for intravenous infusion and contains 500mg per 100mL. The medication guide should be dispensed to each patient, and it should be used immediately after it is removed from the overwrap. It may contain Hydrochloric Acid, NF and/or Sodium Hydroxide, NF to adjust pH 10 38 5.8. Dilution is not required, and additives should not be added simultaneously. It is a single-use container, any unused portion should be discarded. The manufacturer and lot number are provided, but the expiration date was not found.*

This is a description of a medication named Levofloxacin in 5% Dextrose Injection which is used for intravenous infusion. The injection comes in a 150 mL single-dose container with a dilute solution equivalent of 750 mg of levofloxacin (5 mg/mL) in 5% dextrose. It should be infused over 90 minutes and not diluted further. The pharmacist should dispense the accompanying medication guide to each patient. The solution may contain Hydrochloric Acid or Sodium Hydroxide (not confirmed). Additives should not be added or infused simultaneously through the same intravenous line. This injection is only for immediate use after being removed from the overwrap. The usual adult dosage can be found in the insert. The medication is sterile and nonpyrogenic, and it should not be used in series connection. The manufacturer is Gland Pharma Limited in India.*

This is a prescription medication called Levofloxacin in 5% Dextrose Injection. Each 50 mL contains 250 mg of Levofloxacin (5 mg/mL) in a dilute solution equivalent to 260 mg of Levofloxacin in 5% dextrose. It is recommended for intravenous infusion and should be infused over 60 minutes. The medication comes in a single-dose container that should be discarded after use. The usual adult dosage should be reviewed in the insert provided in the packaging. This sterile and non-pyrogenic medication is manufactured by Gland Pharma Limited and should only be used if the solution is clear and the container is undamaged. Please note that it should not be used in series connection, and the accompanying medication guide should be given to each patient.*

The text represents a graph or table that shows plasma concentration measured in sgmL over time (in hours). The first two data points are 12 and 0 at time 0 hours. There is a treatment involving a 750 mg ix tablet with a 90 min infusion. The rest of the data is not available.*

This text provides information regarding plasma concentration of a medication in two different forms: a 500 mg tablet taken orally and a 500 mg dose given intravenously. The unit of measurement is ug/mL.*

This is a description of a bag pouch containing Levofloxacin in 5% Dextrose Injection, with 500mg per 100mL concentration, intended for intravenous infusion. The pouch bears tear-at-notches, NDC 68083-415-01, and a warning for pharmacists to dispense the accompanying medication guide to each patient. The pH range should be adjusted within 3.9-5.8, and the injection should be infused over 50 minutes. The pouch is manufactured by "B. Braun Medical Inc." and includes contact information for "Anikem Laboratories" and "Pharma Limited DP."*

This is a description of an injectable medication in a bag pouch. The medication is Levofloxacin in 5% dextrose injection with a concentration of 750mg per 150 mL. It is administered through intravenous infusion over a period of 10 minutes. There is a tear-notch to open the pouch and a caution to dispense the accompanying medication guide to each patient. The manufacturer is Gand Phamma Limited based in Hyderabad, India. This product information is likely intended for pharmacists or healthcare providers who administer medication.*

This is a description of a medicine, specifically a Levofloxacin in 5% Dextrose Injection, contained in a bag pouch with instructions on how to open, administer, and leave it in overwrap until use. The text includes dosage information as well as the manufacturing company's information.*